We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
AUM
$18.4B
AUM Growth
+$991M
Cap. Flow
+$652M
Cap. Flow %
3.54%
Top 10 Hldgs %
30.84%
Holding
2,900
New
51
Increased
2,117
Reduced
295
Closed
90

Sector Composition

Rank Sector Weight
1 Technology 30.12%
2 Financials 12.96%
3 Consumer Discretionary 11.52%
4 Healthcare 10.04%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMR icon
1276
Alpha Metallurgical Resources
AMR
$2.02B
$1.32M 0.01%
6,621
+219
+3% +$49K
HI
1277
DELISTED
Hillenbrand
HI
$1.32M 0.01%
42,905
+2,362
+6% +$71.4K
COMP icon
1278
Compass
COMP
$10.2B
$1.32M 0.01%
225,711
+12,883
+6% +$81.6K
JWN
1279
DELISTED
Nordstrom
JWN
$1.32M 0.01%
54,669
+4,705
+9% +$109K
HURN icon
1280
Huron Consulting
HURN
$2.39B
$1.32M 0.01%
10,617
+682
+7% +$79.9K
QGEN icon
1281
Qiagen
QGEN
$8.93B
$1.32M 0.01%
28,751
+5,481
+24% +$245K
SXI icon
1282
Standex International
SXI
$4B
$1.32M 0.01%
7,047
+419
+6% +$80.8K
TRMK icon
1283
Trustmark
TRMK
$2.79B
$1.31M 0.01%
37,141
+2,020
+6% +$72.9K
WAFD icon
1284
WaFd
WAFD
$2.79B
$1.31M 0.01%
40,733
+2,039
+5% +$71.6K
MRCY icon
1285
Mercury Systems
MRCY
$6.7B
$1.31M 0.01%
31,189
-478
-2% -$18.2K
WIX icon
1286
WIX.com
WIX
$3.35B
$1.31M 0.01%
6,100
+1,600
+36% +$306K
IDYA icon
1287
IDEAYA Biosciences
IDYA
$3.56B
$1.3M 0.01%
50,615
+3,257
+7% +$92.2K
OPLN
1288
Openlane
OPLN
$4.34B
$1.3M 0.01%
65,486
+3,600
+6% +$66.4K
WRBY icon
1289
Warby Parker
WRBY
$3.13B
$1.3M 0.01%
53,598
+2,561
+5% +$52.3K
CNMD icon
1290
CONMED
CNMD
$1.49B
$1.29M 0.01%
18,886
+1,250
+7% +$87.1K
AVPT icon
1291
AvePoint
AVPT
$2.91B
$1.29M 0.01%
77,985
+4,102
+6% +$62.3K
AIR icon
1292
AAR Corp
AIR
$5.96B
$1.29M 0.01%
21,001
+1,156
+6% +$74.1K
EXTR icon
1293
Extreme Networks
EXTR
$3.2B
$1.28M 0.01%
76,739
+2,672
+4% +$43.2K
BANC icon
1294
Banc of California
BANC
$3.1B
$1.28M 0.01%
82,980
+2,960
+4% +$46.7K
VSH icon
1295
Vishay Intertechnology
VSH
$5.11B
$1.28M 0.01%
75,644
-53,890
-42% -$945K
NEO icon
1296
NeoGenomics
NEO
$2.11B
$1.28M 0.01%
77,403
+2,596
+3% +$40.3K
EFSC icon
1297
Enterprise Financial Services Corp
EFSC
$2.41B
$1.27M 0.01%
22,600
+1,225
+6% +$68.5K
STRA icon
1298
Strategic Education
STRA
$1.81B
$1.27M 0.01%
13,588
+749
+6% +$69.9K
TARS icon
1299
Tarsus Pharmaceuticals
TARS
$3.07B
$1.26M 0.01%
22,678
+1,174
+5% +$53.3K
PHIN icon
1300
Phinia Inc
PHIN
$2.71B
$1.25M 0.01%
25,946
+1,156
+5% +$57.1K

Similar funds

MetLife Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, MetLife Investment Management held 2,900 positions worth $18.4B, up 5.7% from $17.4B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

MetLife Investment Management deployed $652M of net new capital in Q4 2024, opening 51 new positions and adding to 2,117 existing holdings. Its largest new stake was Flex: 211,786 shares worth $8.13M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 30% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Arista Networks, an estimated $13.8M trimmed.

  • MetLife Investment Management's largest Q4 2024 buy was Flex: 211,786 shares worth $8.13M.
  • MetLife Investment Management added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $117M increase.
  • MetLife Investment Management's biggest Q4 2024 reduction was Arista Networks, cutting an estimated $13.8M.
  • MetLife Investment Management fully exited Southwestern Energy Company in Q4 2024, selling an estimated $4.05M.
  • MetLife Investment Management's ten largest holdings make up 31% of its $18.4B portfolio in Q4 2024.
  • MetLife Investment Management opened 51 new positions and closed 90 in Q4 2024.
  • MetLife Investment Management's portfolio value rose 5.7% quarter-over-quarter to $18.4B.

Based on MetLife Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.